Zur Behandlung der Psoriasis mit Hemmern des Wachstumshormons und durch Aktivierung der β-Rezeptoren

  • G. Weber
  • D. Neugebauer
  • M. Neidhardt
Conference paper
Part of the Verhandlungen der Deutschen Dermatologischen Gesellschaft book series (VDGDERMATOLOGIE, volume 33)

Zusammenfassung

Die pathogenetische Kette der Psoriasis reicht von der Erhöhung des Wachstumshormons im Blutserum über die Verminderung der Adenyl-Cyclase und des zyklischen AMP bis zum bekannten morphologischen Substrat der Papillomatose, Akanthose und Parakeratose. Diese Erkenntnis beruht auf den Ergebnissen endokrinologischer, biochemischer, feingeweblicher und spezieller therapeutischer Untersuchungen verschiedener Arbeitskreise der letzten Jahre [1, 14, 21, 25, 33–37].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Adachi K, Aoyagi T, Nemoto O, Halprin KM, Levine V (1981) Epidermal cyclic GMP is increased in psoriasis lesions. J Invest Dermatol 76: 19–20PubMedCrossRefGoogle Scholar
  2. 2.
    Aoyagi T, Adachi K, Halprin KM, Levine V (1980) The effects of epidermal growth factor on the cyclic nucleotide system in pig epidermis. J Invest Dermatol 74: 238–241PubMedCrossRefGoogle Scholar
  3. 3.
    Aoyagi T, Adachi K, Halprin KM, Levine V, Woodyard CW (1981) The effect of histamine on epidermal outgrowth: Its possible dual role as an inhibitor and stimulator. J Invest Dermatol 76: 24–27PubMedCrossRefGoogle Scholar
  4. 4.
    Bansal S, Lee LA, Woolf PD (1981) Dopaminergic modulation of arginine mediated growth hormone and prolactin release in man. Metabolism 30: 649–653PubMedCrossRefGoogle Scholar
  5. 5.
    Bauer FW, Crombag NHCMN, Boezeman JBM, De Grood RM (1981) Flow cytometry as a tool for the study of cell kinetics in skin 2. Cell kinetic data in psoriasis. Br J Dermatol 104: 271–276PubMedCrossRefGoogle Scholar
  6. 6.
    Blackard WG, Heidingsfelder SA (1968) Adrenergic receptor control mechanism for growth hormone secretion. J Clin Invest 47: 1407–1414PubMedCrossRefGoogle Scholar
  7. 7.
    Eriksson E, Edén S, Modigh K (1981) Importance of norepinephrine a2-receptor activation for morphine-induced rat growth hormone secretion. Neuroendocrinology 33: 91–96PubMedCrossRefGoogle Scholar
  8. 8.
    Golde DW, Herschman HR, Lusis AJ, Groopman JE (1980) Growth factors. Ann Intern Med 92: 650–662Google Scholar
  9. 9.
    Goerz G, Merk H (1981) Nicht allergische Arzneimittel-Reaktionen an der Haut. Dermatosen 29: 65–74Google Scholar
  10. 10.
    Greenwood C (1982) The pharmacology of ketotifen. Chest 1, Suppl 45–48Google Scholar
  11. 11.
    Harris RR, Mackenzie IC (1981) The effects of a and ß adrenergic agonists and cyclic adenosine 3′:5′-monophosphate on epidermal metabolism. J Invest Dermatol 77: 337–340PubMedCrossRefGoogle Scholar
  12. 12.
    Hizuka N, Gorden P, Lesniak MA, Van Obberghen E, Carpentier JL, Orci L (1981) Polypeptide hormone degradation and receptor regulation are coupled to ligand internalization. J Biol Chem 256: 4591–4597PubMedGoogle Scholar
  13. 13.
    Holzmann H, Morsches B, Beyer J, Wenzel D, Oertel GW, Krapp R (1972) Hyperinsulinismus und eingeschränkte Glucosetoleranz bei Psoriasis. Arch Dermatol Forsch 245: 95–109PubMedCrossRefGoogle Scholar
  14. 14.
    Holzmann H, Morsches B, Hoede N (1973) Atiopathogenese der Psoriasis-Krankheit. Med Welt 12: 429–434Google Scholar
  15. 15.
    Kirschenbaum MB (1963) Psoriasis following administration of antimalarial Drugs. JAMA 1044Google Scholar
  16. 16.
    Krulich L, Mayfield MA, Steele MK, McMillen BA, McCann SM, Koenig JI (1982) Differential effects of pharmacological manipulations of central αl-and α2-αd-renergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology 110: 796–804PubMedCrossRefGoogle Scholar
  17. 17.
    Lazarus GS, Gilgor RS (1979) Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. Arch Dermatol 115: 1183–1184PubMedCrossRefGoogle Scholar
  18. 18.
    Marcelo CL, Voorhees JJ (1980) Cyclic nucleotides and the control of psoriatic cell function. Cyclic Nucl Res 12: 129–137Google Scholar
  19. 19.
    Mizumoto T, Ohkawara A (1980) The localization of cyclic nucleotides in the human epidermis: An immunohistochemical study. Curr Probl Dermatol 10: 67–81PubMedGoogle Scholar
  20. 20.
    Pelsor DA, Winter RJ, Green OC (1981) Propranololinduced hypoglycemia during growth hormone testing. Brief clinical and laboratory observations 99: 157–158Google Scholar
  21. 21.
    Ragaz A, Ackerman AB (1979) Evolution, maturation, and regression of lesions of psoriasis. New observations and correlation of clinical and histologic findings. Am J Dermatopathol 1: 199–215PubMedCrossRefGoogle Scholar
  22. 22.
    Redmond GP (1981) Effect of ethanol on spontaneous and stimulated growth hormone secretion. Prog Biochem Pharmacol 18: 58–74PubMedGoogle Scholar
  23. 23.
    Rogoz Z, Skuza G, Sowinska H (1981) Central action of ketotifen. Pol J Pharmacol Pharm 33: 503–515PubMedGoogle Scholar
  24. 24.
    Ross EM, Gilman AG (1980) Biochemical properties of hormonesensitive adenylate cyclase. Ann Rev Biochem 49: 533–564PubMedCrossRefGoogle Scholar
  25. 25.
    Schaefer F, Custer RP, Sorof S (1981) Enhancement of squamous cell development in cultured skin by cyclic adenine nucleotide and prostaglandins. Differentiation 20: 260–263PubMedCrossRefGoogle Scholar
  26. 26.
    Steidler NE, Reade PC (1980) An immunohistochemical study of secretagogue-induced secretion of epidermal growth factor in the submandibular salivary glands of mice. AJEBAK 58: 241–247PubMedGoogle Scholar
  27. 27.
    Steiner RA, Illner P, Rolfs AD, Toivola PTK, Gale CC (1978) Noradrenergic and dopaminergic regulation of GH and prolactin in baboons. Neuroendocrinology 26: 15–31PubMedCrossRefGoogle Scholar
  28. 28.
    Stuart CA, Vesely DL, Provow SA, Furlanetto RW (1982) Cyclic nucleotides and somatomedin action in cartilage. Endocrinology 111: 553–558PubMedCrossRefGoogle Scholar
  29. 29.
    Szentivanyi A, Szentivanyi J (1981) Beta-adrenoceptors and antiallergic drugs. In: Proceedings of the Meeting of the European Academy of Allergology and Clinical Immunology, Clermont-Ferrand, Sept. 24th–26th 1981 (in press)Google Scholar
  30. 30.
    Tell G (1973) Somatomedin: Inhibition of adenylate cyclase activity in subcellular membranes of various tissues. Science 180: 312–314PubMedCrossRefGoogle Scholar
  31. 31.
    Terry C, Crowley WR, Johnson MD (1982) Regulation of episodic growth hormone secretion by the central epinephrine system. J Clin Invest 69: 104–112PubMedCrossRefGoogle Scholar
  32. 32.
    Tsai JS, Pasqual A (1981) Effect of bromocriptine on thyroid hormone-induced growth hormone production in cultures GH1 cells. Endocrinology 109: 1306–1308PubMedCrossRefGoogle Scholar
  33. 33.
    Weber G, Neidhardt M (1980) Korrelation zwischen Psoriasis and menschlichem Wachstumshormon. Muench Med Wochenschr 122: 1690–1694Google Scholar
  34. 34.
    Weber G, Neidhardt M, Schmidt A, Geiger A (1981) Korrelation von Wachstumshormon and klinischem Bild der Psoriasis. Arch Dermatol Res 270: 129–140PubMedCrossRefGoogle Scholar
  35. 35.
    Weber G, Klughardt G, Neidhardt M (1981) Psoriasis and human growth hormone: Aetiology and therapy. Arch Dermatol Res 270: 361–365PubMedCrossRefGoogle Scholar
  36. 36.
    Weber G, Neidhardt M, Frey H, Galle K, Geiger A (1981) Treatment of psoriasis with bromocriptin. Arch Dermatol Res 271: 437–439PubMedCrossRefGoogle Scholar
  37. 37.
    Weber G, Klughardt G, Neidhardt M (1982) Treatment of psoriasis with somatostatin. Arch Dermatol Res 272: 31–36PubMedCrossRefGoogle Scholar
  38. 38.
    Whitfield JF, Boynton AL, Macmanus JP, Sikorska M, Tsang BK (1979) The regulation of cell proliferation by calcium and cyclic AMP. Mol Cell Biochem 27: 155–179PubMedCrossRefGoogle Scholar
  39. 39.
    Wilkin J (1981) Exacerbation of psoriasis during clonidine therapy. Arch Dermatol 117: 4PubMedCrossRefGoogle Scholar
  40. 40.
    Wilkinson DI, Liu SCC, Orenberg EK (1981) Cyclic nucleotide content of passaged keratinocytes in culture during various growth stages. J Invest Dermatol 77: 385–388PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • G. Weber
    • 1
  • D. Neugebauer
    • 1
  • M. Neidhardt
    • 1
  1. 1.HautklinikKlinikum NürnbergNürnbergDeutschland

Personalised recommendations